Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use
- PMID: 23066344
- PMCID: PMC3462607
Item in Clipboard
Ipilimumab (yervoy) prolongs survival in advanced melanoma: serious side effects and a hefty price tag may limit its use
P T.
2012 Sep.
Abstract
Ipilimumab (Yervoy) for metastatic melanoma
Similar articles
-
Immunomodulatory therapy for melanoma: ipilimumab and beyond.Clin Dermatol. 2013 Mar-Apr;31(2):191-9. doi: 10.1016/j.clindermatol.2012.08.006. Clin Dermatol. 2013. PMID: 23438382 Free PMC article. Review.
-
The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: summary of the scientific assessment of the Committee for Medicinal Products for Human Use.Eur J Cancer. 2012 Jan;48(2):237-42. doi: 10.1016/j.ejca.2011.09.018. Epub 2011 Oct 24. Eur J Cancer. 2012. PMID: 22030452 Review.
-
Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma.Clin Cancer Res. 2011 Nov 15;17(22):6958-62. doi: 10.1158/1078-0432.CCR-11-1595. Epub 2011 Sep 7. Clin Cancer Res. 2011. PMID: 21900389 Free PMC article. Review.
-
Ipilimumab and cancer immunotherapy: a new hope for advanced stage melanoma.Yale J Biol Med. 2011 Dec;84(4):381-9. Yale J Biol Med. 2011. PMID: 22180676 Free PMC article. Review.
-
Ipilimumab-Based Therapy: Consensus Statement From the Faculty of the Melanoma Nursing Initiative on Managing Adverse Events With Ipilimumab Monotherapy and Combination Therapy With Nivolumab.Clin J Oncol Nurs. 2017 Aug 1;21(4 Suppl):30-41. doi: 10.1188/17.CJON.S4.30-41. Clin J Oncol Nurs. 2017. PMID: 28738054
Cited by
-
NKp30 - A prospective target for new cancer immunotherapy strategies.Br J Pharmacol. 2020 Oct;177(20):4563-4580. doi: 10.1111/bph.15222. Epub 2020 Aug 26. Br J Pharmacol. 2020. PMID: 32737988 Free PMC article. Review.
-
A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint Blockade.Sci Rep. 2019 Aug 2;9(1):11286. doi: 10.1038/s41598-019-47802-4. Sci Rep. 2019. PMID: 31375756 Free PMC article.
-
Immunotherapy: A Challenge of Breast Cancer Treatment.Cancers (Basel). 2019 Nov 20;11(12):1822. doi: 10.3390/cancers11121822. Cancers (Basel). 2019. PMID: 31756919 Free PMC article. Review.
-
Antineoplastic Effects of Ankaferd Hemostat.Biomed Res Int. 2022 Aug 2;2022:2665903. doi: 10.1155/2022/2665903. eCollection 2022. Biomed Res Int. 2022. PMID: 35958818 Free PMC article. Review.
-
Cryptic association of B7-2 molecules and its implication for clustering.Protein Sci. 2021 Sep;30(9):1958-1973. doi: 10.1002/pro.4151. Epub 2021 Jul 10. Protein Sci. 2021. PMID: 34191384 Free PMC article.
References
-
- National Cancer Institute A snapshot of melanoma. Oct, 2011. Available at: www.cancer.gov. Accessed January 16, 2012.
-
- World Health Organization Skin cancers. Available at: www.who.int/uv/faq/skincancer/en/index1.html. Accessed January 16, 2012.
-
- National Cancer Institute SEER stat fact sheets: Melanoma of the skin. Available at: http://seer.cancer.gov/statfacts/html/melan.html. Accessed January 16, 2012.
-
- National Cancer Institute Melanoma treatment (PDQ) Aug, 2011. Available at: www.cancer.gov. Accessed January 17, 2012.
-
- National Comprehensive Cancer Network NCCN practice guidelines in oncology: Melanoma (version 3.2012) Dec 1, 2011. Available at: www.nccn.com. Accessed January 16, 2012.
LinkOut - more resources
Full Text Sources
Other Literature Sources